04 April 2022
We are excited to welcome Stephanie Morris to MTPConnect as the Director of Innovation and Translation for our Adelaide Intermediary Program, based in Adelaide.
Stephanie will work closely with Jo Close, Director Adelaide Intermediary Program, and Adelaide BioMed City partners to deliver activities that strategically build capacity, connection and opportunity and help to drive the growth of health and biomedical innovation and translation in South Australia.
Stephanie is a life-sciences professional with enthusiasm for medical technology commercialisation. She most recently headed the industry partnerships and translational activities for academic discovery and innovation at Imperial College London’s Faculty of Medicine in UK, a world top ten university. Her expertise extends from having worked within start-up companies and SMEs to large multinational pharmaceutical organisations at operational and governance levels. She brings experience from across the full care continuum, including academia, R&D, clinical development, commercialisation, as well as working with patients in both acute and chronic settings in the community.
Stephanie holds a MBA from the University of South Australia, is a Graduate of the Australian Institute of Company Directors (GAICD), a Certified Licensing Professional (CLP), and has graduate qualifications in both Business and Biomedical Science. She is also Deputy Chair for Cure4CF Foundation, a not-for-profit organisation driven to find a cure for cystic fibrosis.
Please join us in giving Stephanie a warm welcome.